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Summary  The  Embryonic  Stem  Cell  Test  (EST)  developed  in  Germany  in  1997  is  known  as
a screening  test  method  capable  of  predicting  the  presence  of  unknown  chemicals  inﬂuenc-
ing normal  human  development.  Firstly,  we  investigated  the  embryotoxicity  of  24  types  of
monomer  including  dental  monomers  and  dental  alloy-component  metal  elements  using  this
test. Monomers  including  Bis-GMA  contained  in  base  resin  of  composite  resin  exhibited  weak
embryotoxicity,  and  the  toxicity  level  varied  among  dental  alloy-component  metal  elements.  It
was clariﬁed  that  metal  ions  eluted  from  currently  sold  dental  alloys  show  no  embryotoxicity.
Then, we  investigated  a  method  that  also  considers  human  metabolic  activity,  which  is  not  pos-
sible with  the  EST,  in  the  results  of  embryotoxicity.  In  addition,  an  evaluation  method  using  a
hybrid culture  system  for  hepatocytes  and  mouse  ES  cells  and  a  method  using  oviduct  or  uterus
cells for  feeder  cells  were  also  investigated.
© 2016  Japanese  Association  for  Dental  Science.  Published  by  Elsevier  Ltd.  This  is  an  open  access
article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).ontents
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Figure  1  The  improved  prediction  model  (iPM).  The  mathe-
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dmatical  formula  to  predict  the  embryotoxicity  risk  level  by  the
three endopoints.
1. In vitro embryotoxicity test method
The  inﬂuence  of  chemical  substances  on  human  fetal  devel-
opment  is  of  marked  concern.  Thalidomide  [1,2]  is  a
chemical  substance  known  to  inﬂuence  human  fetuses,  but
the  presence  of  as  yet  unknown  toxic  chemical  substances
among  those  whose  inﬂuence  has  not  been  fully  conﬁrmed
cannot  be  ruled  out.  The  embryotoxicity  lacks  clinical
data,  unlike  general  cytotoxicity,  and  systematic  elucidation
remains  insufﬁcient.  Thus,  it  is  possible  that  novel  synthetic
chemical  or  natural  substances  show  toxicity.  Only  experi-
mental  methods  using  animals  were  previously  available  to
assess  embryotoxicity,  and  no  in  vitro  screening  method  has
been  fully  established.
The  Embryonic  Stem  Cell  Test  (EST)  developed  in
Germany  in  1997  [3]  is  an  in  vitro  screening  method  capable
of  predicting  the  embryotoxicity  risk  of  chemical  substances
contained  in  dental  materials  and  drugs.  It  is  an  in  vitro
embryotoxicity  test  method  using  3  parameters:  the  dif-
ferentiation  and  viability  of  mouse-derived  ES-D3  cells  and
viability  of  Bulb/c  3T3  cells.  The  3  parameters  are  applied
to  equations  of  improved  Prediction  Model  (iPM,  Fig.  1),  and
the  test  substance  is  classiﬁed  into  3  categories:  ‘‘strongly’’,
‘‘weakly’’,  and  ‘‘non-embryotoxic’’.  The  ES-D3  and  Bulb/c
3T3  cells  used  are  shown  in  Fig.  2,  and  each  culture  medium
is  shown  in  Table  1.  International  validation  of  the  EST  has
Table  1  Mediums  of  both  cells.
ES-D3  cells Balb  c/3T3  cells
20%  FCS  10%  FCS
2 mM  L-glutamine  4  mM  L-Glutamine
50 IU  Penicillin  50  IU  Penicillin
50 g  Streptmycin 50  g  Streptmycin
1% NAA
0.1 mM  ˇ-Mercaptoethanol
1000  U/mL  mLIF
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een  performed  in  Europe  by  comparison  with  other  in  vitro
mbryotoxicity  test  methods  (micro  mass  culture  and  whole
mbryo  culture  methods)  [4—6].
In  European  REACH  (Registration,  Evaluation,  Authoriza-
ion  and  Restriction  of  CHemicals)  aimed  at  re-evaluation
f  the  safety  of  chemical  substances,  biological  safety  eval-
ation  is  required  for  all  chemical  substances  already  sold
n  Europe,  including  novel  synthetic  and  natural  chemical
ubstances.  If  these  chemical  substances  can  be  evaluated
n  vitro  without  using  an  experimental  animal,  it  would
e  advantageous  economically,  temporally,  and  statistically,
nd  REACH  also  recommends  it  from  the  viewpoint  of  animal
elfare  [7—9].
The  EST  was  demonstrated  to  be  more  strongly  corre-
ated  with  human  teratogenicity  compared  to  the  other  2
ethods.  Using  the  EST  protocol,  we  investigated  various
onomers  and  dental  alloy  components.  Eighteen  types  of
onomer  including  dental  monomers  (1.6-ADMA,  1.8-ADMA,
.10-ADMA,  2.0-EpDMA,  3.0-EpDMA,  4.0-EpDMA,  6-HHMA,
is-GMA,  Bis-GMA  (6F),  Bis-MPEPP,  BPE-1300,  BSNa,  EDMABA,
AM,  GMR,  UDMA,  MEPC,  MTYA,  Phosmer  M,  PTSNa,  QTX
nd  TEGDMA,  Fig.  3) were  investigated.  The  3  parameters
ere  applied  to  Equations  I,  II,  and  III  of  the  iPM  to  inves-
igate  the  embryotoxicity  risk.  6-HHMA,  Bis-GMA,  Bis-GMA
6F),  Bis-MPEPP,  MTYA,  UDMA,  and  TEGDMA  were  Class  2,
‘weak  embryotoxicity’’.  The  other  monomers  were  Class
,  ‘‘non  embryotoxicity’’,  and  no  monomer  showed  ‘‘strong
mbryotoxicity’’  (Table  2).  It  was  clariﬁed  that  monomers
ncluding  Bis-GMA  contained  in  base  resin  of  composite  resin
how  weak  embryotoxicity  [10—12].
Twelve  dental  alloy-component  metals:  Ag,  Co,  Cr,  Cu,
g,  In,  Ni,  Pd,  Sb,  Sn,  V,  and  Zn,  were  subjected  to
he  embryotoxicity  test  employing  the  EST  using  standard
eagents  for  atomic  absorption  measurement.  Hexavalent
r  and  Hg  ions  were  class  3,  i.e.,  ‘‘strongly  embryotoxic’’.
n,  Sn,  Sb,  and  V  were  ‘‘weakly  embryotoxic’’,  and  the
ther  metal  ions  were  ‘‘non-embryotoxic’’.  In  addition,  test
amples  of  Ag,  Co,  Cr,  Ni,  and  Pd  were  prepared  by  direct
xtraction  from  each  metal  powder  in  medium  and  sub-
ected  to  the  test.  Only  Ag  was  ‘‘weakly  embryotoxic’’,
howing  embryotoxicity,  but  all  other  metal  ions  were  ‘‘non
embryotoxic’’.  Hexavalent  Cr  showed  strong  embryotox-
city,  but  trivalent  Cr  was  ‘‘non-embryotoxic’’.  Currently,
hese  metal  ions  are  not  used  in  dental  care  [13].
In  addition,  the  elution  of  metal  ions  into  saliva  markedly
ecreases  in  the  presence  of  oxide  ﬁlm  on  the  dental  alloy
urface.  Particularly,  the  rates  of  elution  of  alloy-component
ons  from  dental  cobalt-chromium  and  silver  alloys  into  the
ral  cavity  are  low  due  to  the  presence  of  an  inert  ﬁlm  on  the
lloy  surface.  Thus,  the  inﬂuence  of  metal  ions  eluted  from
hese  dental  alloys  on  embryotoxicity  may  be  negligible.
.  Modiﬁcation of EST protocol
he  embryotoxicity  level  of  mercury  varied  depending  on
he  ion  extraction  conditions.  The  strong  embryotoxicity  of
g  ions  was  clariﬁed,  but  dentists  and  patients  may  not
e  exposed  to  Hg  because  amalgam  is  no  longer  used  in
ental  care.  However,  amalgam  remains  in  the  oral  cavity
ainly  in  elderly  patients,  and  mercury  vapor  from  amalgam
resent  in  their  teeth  is  of  concern.  Mercury  vapor  markedly
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sigure  2  (a)  Embryonic  stem  cells,  D3,  obtained  from  Prof.  
T3 cells.
nﬂuences  human  health,  unlike  metal  mercury.  To  develop
n  in  vitro  embryotoxicity  test  method  for  mercury  vapor,
e  investigated  the  application  of  the  roller  tube  culture
ethod,  in  which  a  large  culture  bottle  containing  mercury
apor  generated  by  heating  metal  mercury  and  medium  was
i
t
t
i
Figure  3  The  structural  formKemler  (Max  Planck  Institute,  Freiburg,  Germany).  (b)  Balb/c
lowly  rotated  to  directly  expose  cells  to  the  phase  contain-
ng  mercury  vapor  (Fig.  4).  The  results  on  ES  cells  exposing
o  mercury  vapor  were  different  from  those  on  exposure
o  metal  mercury.  A  very  strong  inﬂuence  was  noted  lead-
ng  to  the  impairment  of  beating  which  develops  through
ula  of  various  monomers.
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Table  2  Embryotoxicity  risk  of  monomers.
Embryotoxicity  level  Monomers
Strong  (III)  None
Weak  (II)  6-HHMA,  Bis-GMA,  Bis-GMA(6F),  MTYA,  Bis-MPEPPa,  TEGDMAa,  UDMAa
None  (I)  1,6-ADMA,  1,8-ADMA,  1,10-ADMA,  2.0  EpDMA,  3.0  EpDMA,  4.0  EpDMA,  BPE-1300,  BSNa,  GMA,  GAM,
EDMABA, Phosmer  M,  PTSNa,  QTX
a These monomers are boundary area between I.
Figure  4  Exposure  to  mercury  vapor  using  the  rotary  culture  bottle.  We  constructed  a  heat-driven  mercury  evaporator  consisting
of a  bottle  equipped  with  a  100-V  built-in  electric  heater  on  the  lid  and  a  stainless-steel  rod  with  a  slight  dent  at  the  tip.  The  lid
of the  culture  bottle  was  removed  after  a  rotary  culture,  and  the  mercury  evaporator  with  5.0  g  or  2.0  g  of  mercury  at  the  tip
of the  stainless-steel  rod  was  placed  inside  the  bottle.  Mercury  evaporated  completely  after  the  electricity  was  turned  on  and  the
stainless-steel  rod  was  heated  for  10  min.  After  changing  the  lid,  a  rotary  culture  was  done  at  37 ◦C  for  three  days  in  an  incubator
(New Brunswick).
Figure  5  (a)  Results  of  the  EBs  differentiation  in  mercury  vapour.  The  mercury  exposure  concentrations  were  5.0  g  and  2.0  g,
no cell  pulsations  were  observed,  whereas  in  the  control  group  with  no  mercury  exposure,  myocardial  cell  pulsations  were  observed
in 84.0%  of  the  wells.  (b)  Results  of  cell  viability  in  mercury  vapour  with  MTT  method.  The  mercury  exposure  concentration  was
5.0 g,  the  cell  viability  was  68%  of  that  of  the  control  group.  Also,  in  the  group  where  the  mercury  exposure  concentration  was
2.0 g,  the  cell  viability  was  96.0%  of  that  of  the  negative  control  group.
58  K.  Imai
Figure  6  (a)  Three-dimensional  cell  culture.  Collagen  gel  or  sponge  was  placed  in  cell  culture  inserts,  and  300  L  of  medium
was poured  into  the  cell  culture  insert,  with  1.6  mL  of  medium  being  poured  in  the  wells  of  a  12-well  multi-dish.  (b)  Osteocalcin
levels. After  21  days  of  culture,  the  levels  of  the  bone  differentiation  marker  mouse  osteocalcin  were  measured  by  ELISA  assay  kit
(Biomedical Technologies,  Inc.,  USA).  The  mean  osteocalcin  value  was  2.139  for  CG  and  1.664  for  CS,  whereas  the  level  detected  for
FC was  not  signiﬁcantly  different  from  that  observed  for  the  negative  control  group.  (c)  A  collagen  gel  (Nitta  Gelatin,  Osaka)  derived
from porcine  (Type  I-A  and  Type  III  collagens  mixed  in  a  3:1  ratio  by  volume;  CG),  a  collagen  gel  derived  from  chum  salmon  (Ihara  &
Co., Ltd.,  Rumoi,  Hokkaido,  Type  I;  FC)  and  a  collagen  sponge  derived  from  porcine  (Nitta  Gelatin,  Type  I;  CS)  were  placed  separately
in 10  mm-diameter  cell  culture  inserts  (Falcon,  USA)  and  ﬁxed  onto  a  membrane  ﬁlter  at  the  bottom  of  each  insert  (Gibco).  Then,
300 L  of  medium  was  poured  into  the  cell  culture  insert,  with  1.6  mL  of  medium  being  poured  in  the  12-well  multi-dish  (Falcon).
The dishes  were  cultured  in  a  CO2 incubator  for  24  h.  Two  EBs  per  well  were  placed  on  a  scaffold  and  cultured  in  a  CO2 incubator
for up  to  21  days.  The  cells  were  photographed  under  an  inverted  phase-contrast  microscope  (Olympus,  Tokyo)  after  4,  10,  and
21 days  of  culture.  In  CG  and  CS,  after  21  days  of  culture,  numerous  oval  structures  and  needle-like  structures,  respectively,  were
observed, whereas  no  such  structures  were  observed  in  FC.
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Figure  7  (a)  TEST  LIVERTM-human  (Toyobo,  Osaka).  (b)  Com-
parison  of  ES-D3  cell  differentiation  rate  by  metabolic  activity  in
thalidomide.  (N  =  4).  The  contraction  rate  of  the  TEST  LIVERTM-
human culture  with  thalidomide  concentration  0.31  mg/mL  was
signiﬁcantly  lower  than  that  of  the  non-using  TEST  LIVERTM-
human  group.  (c)  Comparison  of  ES-D3  cell  differentiation  rate
due to  metabolic  activity  of  ﬁve  metal  ions  (N  =  4).  Ag  and  Sn,
slightly  decreased  the  contraction  rate.  In  contrast,  Cu  and  Zn
slightly increased  the  contraction  rate  in  the  TEST  LIVERTM-
human  culture  compared  with  the  TEST  LIVERTM-human  non  use.
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differentiation  from  EB  to  myocardial  cells  (Fig.  5).  Although
the  experimental  conditions,  such  as  exposure  time,  were
different  from  those  in  the  test  with  metal  mercury,  mercury
vapor  showed  strong  embryotoxicity  [14].
Chemical  substances  enter  the  human  body  through  var-
ious  routes  in  vivo. Only  one  chemical  substance  can  be
tested  each  time  using  the  EST,  but  many  chemical  sub-
stances  are  mixed  in  most  dental  materials  and  drugs.  Thus,
it  is  necessary  to  assess  the  embryotoxicity  risk  of  each  indi-
vidual  chemical  component  and  make  a  judgment  based  on
the  overall  results.  However,  risk  assessment  of  mixtures
remains  to  be  further  investigated  because  a  synergistic
effect  is  observed  in  general  toxicity.
It  is  a  disadvantage  of  the  EST  protocol  that  the  inﬂuence
of  human  metabolic  activity  is  not  reﬂected  because  of  the
use  of  mouse-derived  ES  and  Bulb/c  3T3  cells.  The  chemi-
cal  structure  of  substances  may  be  changed  by  metabolism
in  the  liver,  and  the  embryotoxicity  level  may  change  in
the  actual  body.  In  addition,  the  solubility  of  chemical  sub-
stances  in  culture  medium  is  important,  which  is  common
to  in  vitro  cytotoxicity  experiments.  For  water-insoluble
chemical  substances,  the  EST  protocol  speciﬁes  dissolving
it  in  a  solvent,  such  as  ethanol  and  DMSO,  and  then  cul-
ture  medium.  However,  even  though  the  solvent  becomes
transparent  by  stirring  and  the  chemical  substance  appears
to  have  completely  dissolved,  the  solution  becomes  milky
white  and  precipitates  when  it  is  added  to  culture  medium.
When  a  substance  cannot  be  completely  dissolved,  cyto-
toxicity  is  likely  to  be  reduced,  decreasing  the  accuracy  of
evaluation.  We  prepared  a  3-dimensional  model  by  mixing
cells  in  collagen,  referring  to  a  commercial  3-dimensional
skin  model,  and  developed  a  method  to  directly  exposed
it  to  a  chemical  substance  without  the  need  for  a  solvent
(Fig.  6a—c).  Considering  the  results  of  the  present  study,  we
concluded  that  collagen  derived  from  salmon  cannot  be  used
for  differentiation  of  ES-D3  cells  [15,16].
We  investigated  the  inﬂuences  of  thalidomide  and  den-
tal  metal-component  elements  (Ag,  Cu,  Pd,  and  Zn)  on
embryotoxicity.  The  culture  supernatants  of  commercial
TEST  LIVERTM-human  (Fig.  7a),  which  can  be  cultured  for  a
prolonged  period  while  maintaining  human  liver  functions,
and  mouse  ES-D3  cells  were  mixed,  and  the  contractile  rate
of  heart  muscle  that  had  differentiated  from  EBs  prepared
by  hanging-drop  culture  of  ES-D3  cells  was  investigated.  The
heart  muscle  contractile  rate  was  66.7%  in  the  groups  with-
out  the  addition  of  a  test  sample.  Thalidomide  has  been
reported  to  clinically  show  strong  embryotoxicity  (Fig.  7b).
The  differentiation  rate  of  EBs  was  signiﬁcantly  decreased
by  Ag  and  thalidomide,  but  it  was  slightly  increased  by  Cu
and  Zn.  No  signiﬁcant  difference  due  to  the  addition  of  Pd
was  noted  (Fig.  7c)  [17].  The  reduction  of  the  differentiation
rate  of  EBs  by  thalidomide  was  smaller  in  the  absence  than
presence  of  metabolic  activation,  suggesting  that  metabolic
activation  made  the  ﬁndings  more  consistent  with  human
clinical  data.  On  the  other  hand,  there  are  no  human  clini-
cal  data  on  embryotoxicity  with  which  the  inﬂuence  of  metal
ions  on  cell  differentiation  can  be  compared.  Moreover,  all
metal  elements  investigated  are  frequently  used  as  den-
tal  alloy  components.  Therefore,  the  further  collection  of
embryotoxicity  data  and  their  careful  analysis  are  necessary.
Regarding  cytotoxicity,  the  correlation  of  cell  viability  with
metabolic  activation  obtained  using  rat  TEST  LIVERTM with
l
a
td showed  no  signiﬁcant  difference  in  the  TEST  LIVERTM-human
ulture compared  with  the  TEST  LIVERTM-human  non  use.
nimal  study  data  is  stronger  than  that  of  the  data  without
etabolic  activation,  but  more  accurate  data  may  be  col-ected  by  modifying  the  culture  time  to  introduce  metabolic
ctivity  and  the  experimental  method.
Aiming  at  the  development  of  a  method  to  evaluate  hepa-
ocytes  and  mouse  ES  cells  using  a hybrid  culture  system,
60  K.  Imai
Figure  8  (a)  Human  hepatocytes  and  human  liver  cancer  HEpG2  cells.  Human  hepatocytes  (HF,  Celsis  IVT,  BioreclamationIVT.com,
MD, USA),  mouse  hepatocytes  (MF,  Celsis  IVT),  and  human  liver  cancer  HEpG2  cells  (HG,  ATCC:HB-8065)  were  used.  (b)  A  two-
dimensional culture  system  was  prepared  with  hepatocytes  encapsulated  in  collagen  gel  (a  mixture  of  Types  I  and  III  (Nitta  Gelatin
Inc., Osaka))  placed  inside  the  12-well  cell  culture  inserts  (Becton,  Dickinson  and  Co.,  NJ,  USA)  and  embryoid  bodies  (EBs)  prepared
by the  suspension  culture  of  ES-D3  cells  placed  outside.  Conversely,  an  additional  system  was  prepared  with  EBs  encapsulated  in
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collagen gel  placed  inside  the  12-well  cell  culture  inserts  and  h
.1% gelatin  solution  (STEMCELLTM Technologies  Inc.,  Canada)  f
e  compared  2  types  of  scaffold  between  the  basic  struc-
ure  of  the  hybrid  culture  system  and  3-dimensional  culture
ethod  to  prepare  a  speciﬁc  hybrid  culture  system  method
or  3  types  of  cultured  hepatocyte  and  mouse  ES  cells.
uman-  and  mouse  liver-derived  ﬂoating  cells  and  human
iver  cancer-derived  HepG2  cells  were  enclosed  in  collagen
el.  The  3  types  of  hepatocytes  were  placed  in  the  inner
ell  and  EBs  were  placed  in  the  outer  region,  or  EB  was
nclosed  in  collagen  and  placed  in  the  inter  cell  and  the
 types  of  hepatocytes  were  placed  in  a  12-well  multidish
n  which  the  bottom  was  treated  with  0.1%  gelatin  solution
or  one  hour  beforehand  (Fig.  8a  and  b).  The  contractile
evelopment  rate  was  slightly  higher  when  EB  was  placed  in
he  inter  cell  [18].  These  culture  techniques  are  likely  to  be
eferred  to  in  order  to  develop  hybrid  culture  systems  in  the
uture.
Regarding  ES  cell  differentiation,  since  the  original  inner
ell  mass  of  ES  cells  interacts  with  the  oviduct  or  uterus  cells
n  the  body,  intercellular  communication  between  these  and
S  cells  may  be  established  for  normal  cell  division  in  the
ody.  Thus,  we  investigated  ES  cell  differentiation  using
p
t
d
focytes  seeded  onto  a  12-well  multi-dish  bottom  treated  with  a
 hour.
ouse  reproductive  organ-derived  uterus  cells  and  oviduct-
erived  primary  cells  as  a  feeder  layer.  When  3  types  of
terus-derived  cell  and  oviduct-derived  primary  cells  were
sed  as  feeder  cells,  the  results  differed  among  the  feeder
ell  types  (Fig.  9).  The  ES  cell  differentiation  rate  decreased
n  a  feeder  layer  comprised  of  feeder  cells  and  mixed  cells
howing  atypia  in  their  size  and  morphology  [19].
We  are  planning  to  further  modify  the  EST,  which  is  an
n  vitro  embryotoxicity  test  method.  We  are  also  investigat-
ng  the  application  of  these  results  to  not  only  ES  but  also
PS  cells.
In  Japan,  a  contract  research  organization  for  imple-
enting  the  biological  safety  tests  as  a  pre-clinical  study.
n  a few  cases,  EST  is  already  beginning  to  be  described
n  the  test  menu.  Furthermore,  JaCVAM  (Japanese  Center
or  the  Validation  of  Alternative  Methods)  are  beginning  to
onsider  the  embryonic  toxicity  screening  test  (Hand1-Luc)
rotocol  as  an  establish  guideline  for  new  alternative  animal
est  method  about  the  same  procedure  as  EST  protocol.  Vali-
ation  of  this  new  protocol  will  start  examined  by  JaCVAM
rom  February  of  this  year.
Development  of  technique  to  measure  embryotoxicity  61
Figure  9  Comparison  of  inverted  phase  contrast  microscope  images  of  human  hepatocytes  used  in  the  feeder  cells.  The  uterus  and
oviduct tissues  of  an  11-week-old  DBA/2NCrlCrlj  mouse  were  cut  into  fragments,  followed  by  treatment  with  a  0.25%  trypsin/EDTA
solution (Invitrogen,  CA,  USA).  The  fragments  were  centrifuged  several  times,  placed  in  a  25-mL  culture  ﬂask  with  8  mL  of  DMEM
(Gibco, NY,  USA)  supplemented  with  FCS  (HycloneR,  UT,  USA)  at  a  volume  rate  of  10%,  and  cultured  for  seven  days  in  a  CO2 incubator
at 37 ◦C.  Cells  that  reached  conﬂuence  on  the  ﬂask  bottom  after  14-day  culture  were  plated.  The  ﬂasks  were  divided  into  S  (1)—(3)
and O  (1)—(3)  for  uterine-  and  oviduct-derived  cells,  respectively.  The  cells  were  plated  into  a  12-well  dish  and  cultured  for  24  h,
followed by  treatment  with  mitomycin  C  (Wako  Pure  Chemical  Industries,  Ltd.,  Osaka,  Japan)  for  two  hours.  EL  M3  cells  were
purchased from  the  RIKEN  BioResource  Center  (Tsukuba,  Japan).  EBs,  prepared  from  the  suspension  culture  of  EL  M3  cells  (mouse
ES cells),  were  carefully  placed  onto  the  feeder  layer  and  cultured  for  seven  days.  Commercial  MEF  (ReproCell  Inc.,  Kanagawa,
Japan) was  used  as  a  control  feeder  layer.  The  S  (1)—(3)  and  O  (1)—(3)  cells  at  1  ×  104 cells/mL  were  mixed  on  ice,  followed  by  the
addition of  reconstitution  buffer  (Nitta  Gelatin).  The  contraction  rate  under  thalidomide-free  conditions  was  66.7%  for  the  MEF.
The contraction  rates  of  uterine-derived  S  (1)—(3)  and  oviduct-derived  O  (1)—(3)  were  60  and  66.7%,  respectively.  No  signiﬁcant
difference was  noted  between  the  uterine-  or  oviduct-derived  cells  and  the  MEF.  The  oviduct-derived  cells  showed  a  slightly  lower
average value,  although  some  showed  higher  contraction  rates  than  the  MEF.
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